Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis

被引：3
|
作者：
Singal, Amit G. [1 ,4 ]
Nagar, Saurabh P. [2 ]
Hitchens, Abby [2 ]
Davis, Keith L. [2 ]
Iyer, Shrividya [2 ,3 ]
机构：
[1] UT Southwestern Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX USA
[2] RTI Hlth Solut, Res Triangle Pk, NC USA
[3] Eisai Inc, Woodcliff Lake, NJ USA
[4] Digest Dis Ctr, Div Digest & Singal, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2023年 / 21卷 / 03期
关键词：
SORAFENIB;
D O I：
10.1016/j.cgh.2021.11.020
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions: Multicenter analysis
    Hiraoka, Atsushi
    Kumada, Takashi
    Kariyama, Kazuya
    Takaguchi, Koichi
    Atsukawa, Masanori
    Itobayashi, Ei
    Tsuji, Kunihiko
    Tajiri, Kazuto
    Hirooka, Masashi
    Shimada, Noritomo
    Shibata, Hiroshi
    Ishikawa, Toru
    Ochi, Hironori
    Tada, Toshifumi
    Toyoda, Hidenori
    Nouso, Kazuhiro
    Tsutsui, Akemi
    Itokawa, Norio
    Imai, Michitaka
    Joko, Kouji
    Hiasa, Yoichi
    Michitaka, Kojiro
    CANCER MEDICINE, 2019, 8 (01): : 137 - 146
  • [42] Efficacy and Safety of Lenvatinib Therapy for Unresectable Hepatocellular Carcinoma in a Real-World Practice in Korea
    Goh, Myung Ji
    Oh, Joo Hyun
    Park, Yewan
    Kim, Jihye
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    LIVER CANCER, 2021, 10 (01) : 52 - 62
  • [43] Real-world experience of pembrolizumab plus lenvatinib in unresectable hepatocellular carcinoma in Taiwan.
    Wu, Chi-Jung
    Hung, Ya-Wen
    Lee, Pei-Chang
    Lee, ChiehJu
    Chen, Ming Huang
    Chao, Yee
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Real-World Comparative Effectiveness of Nivolumab versus Pembrolizumab in Patients with Unresectable Hepatocellular Carcinoma
    Kuo, Hsin-Yu
    Han, Meng-Zhi
    Liao, Chih-Hsiang
    Lin, Yih-Jyh
    Wang, Chung-Teng
    Chen, Shang-Hung
    Chang, Ting-Tsung
    Chen, Po-Jun
    Lin, Sheng-Hsiang
    Chen, Chiung-Yu
    Chuang, Chiao-Hsiung
    Wu, I-Chin
    Wu, Juei-Seng
    Hong, Tzu-Chun
    Hsieh, Ming-Tsung
    Lee, Yang-Cheng
    Wu, Hung-Tsung
    Tsai, Hong-Ming
    PHARMACEUTICS, 2022, 14 (11)
  • [45] Real-world effectiveness and safety of ramucirumab in hepatocellular carcinoma patients: A retrospective study in Taiwan
    Hung, Min Hua
    Chang, Kaicheng
    Chen, Hui-Yu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 342 - 342
  • [46] Risk Factors for Hepatocellular Carcinoma in Patients with Nonalcoholic Steatohepatitis
    hashizume, Hiroaki
    Sato, Ken
    Ichikawa, Takeshi
    Kakizaki, Satoru
    Takagi, Hitoshi
    Mori, Masatomo
    GASTROENTEROLOGY, 2009, 136 (05) : A847 - A847
  • [47] Real-world effectiveness and safety of TACE combined with lenvatinib plus immune checkpoint inhibitors in patients with BCLC-B stage hepatocellular carcinoma
    Yao, Yu
    Nong, Xiang
    Liang, Jing-Chang
    Zhang, Yu-Mei
    Zhang, Zhi-Ming
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2025, 16 (01) : 176 - 190
  • [48] Effectiveness and safety of lenvatinib plus anti-programmed death-1 antibodies in patients with hepatocellular carcinoma: A real-world cohort study
    Xu, Ming-Hao
    Huang, Cheng
    Li, Mei-Ling
    Zhu, Xiao-Dong
    Tan, Chang-Jun
    Zhou, Jian
    Fan, Jia
    Sun, Hui-Chuan
    Shen, Ying-Hao
    CANCER MEDICINE, 2023, 12 (08): : 9202 - 9212
  • [49] ANALYSIS OF FACTORS RELATED TO THE TOLERABILITY OF LENVATINIB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CONDITIONS: A MULTICENTER STUDY
    Taniki, Nobuhito
    Nakamoto, Nobuhiro
    Chu, Po-Sung
    Shiba, Shunsuke
    Tahara, Toshiyuki
    Komatsu, Hirokazu
    Okamura, Yukishige
    Ojiro, Keisuke
    Kikuchi, Masahiro
    Aoki, Yu
    Yamaguchi, Akihiro
    Usui, Shingo
    Kanai, Takanori
    HEPATOLOGY, 2020, 72 : 689A - 689A
  • [50] The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Sakamoto, Azusa
    Marusawa, Hiroyuki
    Kojima, Yuji
    Hasebe, Chitomi
    Arai, Hirotaka
    Joko, Kouji
    Kondo, Masahiko
    Tsuji, Keiji
    Sohda, Tetsuro
    Kimura, Hiroyuki
    Ogawa, Chikara
    Uchida, Yasushi
    Wada, Shuichi
    Kobashi, Haruhiko
    Furuta, Koichiro
    Shigeno, Masaya
    Kusakabe, Atsunori
    Akahane, Takehiro
    Narita, Ryoichi
    Yoshida, Hideo
    Mitsuda, Akeri
    Ide, Yasushi
    Matsushita, Tomomichi
    Izumi, Namiki
    CANCERS, 2021, 13 (11)
12345